Preview

Pharmacology and Betty

Good Essays
Open Document
Open Document
374 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Pharmacology and Betty
A capital improvement Betty could implement is leasing out a portion of her land to existing or future Alpaca owners. If Betty does not have a mortgage on her property, leasing out a portion of her land would generate immediate income. For instance, let’s say Betty owns five acres of land and decides to lease out one acre for a rental rate of $1,000.00 a month. This additional income would yield $12,000 annually. Betty could use a portion of this money to reinvest into her business while receiving tax-write offs; and could use the extra cash for reinvestment. Additionally, over the course of a long-term lease, Betty most likely will have to add infrastructure to the property to grow the operation. Some of the questions for Betty to consider concerning any capital improvements include: What key of improvements will need to be made? Who will pay for the improvements (Betty or lessee)? If lessee pays for the initial construction of the improvements, Betty should consider paying the lessee the depreciated value once the lease is terminated.

Pfizer is the world’s largest research based, pharmaceutical company. Its capital structure is designed to support the organizations debt, equity and market risk premium. Currently, Pfizer Inc. has three major core business segments: pharmaceutical, consumer health and animal health. In 2003, over 1 billion prescriptions were written for Pfizer medicines (Berardi, 2006) With all of their success and market dominance, one key challenge Pfizer experiences when protecting its assets is protecting its patents. For instance, bringing drugs successfully to the market starting with the ‘beakers in the lab” to obtaining patents can be very costly. Thus, in order to ensure its success, Pfizer has a four phase process which consists of Phase 1: testing on healthy human populations; Phase 2: testing on diseased populations; Phase 3: applying drugs to a large patient population and pitted against competitors in the market and also approved

You May Also Find These Documents Helpful

  • Good Essays

    The team viewed the video “Cost of Capital” as part of our weekly team discussion. In the video, Amil Singh discussed the cost of capital for Pfizer Inc. Pfizer Inc. is the world 's largest research-based pharmaceutical company that develops its own products in America. Pfizer revenue is about $65 billion with market gap close to $140 billion (John Wiley and Sons, 2012). The cost of capital is the "rate of return that capital could expect to earn in an alternative investment of equivalent risk" (Investopedia LLC, 2015). When the company researches and develops a new product it can take nearly eight to ten years before it hits the market and see a profit. In this paper, we will look at how Pfizer addresses its cost of capital and issues with research and development.…

    • 865 Words
    • 3 Pages
    Good Essays
  • Good Essays

    Enabling mighty competition between commonplace drug treatments and patent-expired fashioned brands is relevant to decreasing pharmaceutical charges and stimulating innovation. However, this mentioned, there are numerous troubling problems surrounding general medicines because of the convenient access to an abundance of illegal generics on the internet breaking the patent ownership and the unregulated companies that produce and supply them. At the same time familiar medicines will have to be approved identical types of depended on drugs, providing the equal fine, safety and efficacy because the normal, that is commonly no longer the case. A conventional drug must endure strict scrutiny before it is licensed and given market approval with the aid of countrywide medicines authorities. In brief, common medicines will have to comply with the same strict standards of great, safety and efficacy as usual pharmaceutical…

    • 490 Words
    • 2 Pages
    Good Essays
  • Satisfactory Essays

    5. Analyze the way PharmaCARE uses U.S. law to protect its own intellectual property while co-opting intellectual property in Colberia.…

    • 472 Words
    • 2 Pages
    Satisfactory Essays
  • Better Essays

    Gertrude Belle Elion The scientist I chose is Gertrude Belle Elion. She is a biochemist and a pharmacologist (Biography.com). She impacted the world of science greatly, especially in the area of medicine. She lived until the age of 81 in New York (Nobelprize.org).…

    • 863 Words
    • 4 Pages
    Better Essays
  • Powerful Essays

    Strategy: Pfizer is the world’s number one pharmaceutical company. Its best-selling products include Lipitor, the world’s best- selling medicine, and eight of the top twenty-five medicines in the world. Acquisition of successful competitors such as Pharmacia and Warner Lambert has helped Pfizer to offer best-selling products and further differentiate itself from competitors. The acquisition of the latter company helped bring Lipitor under Pfizer’s control.…

    • 3675 Words
    • 15 Pages
    Powerful Essays
  • Satisfactory Essays

    Merck Executive Summary

    • 496 Words
    • 2 Pages

    Merck & Co., Inc., a leading pharmaceutical company, faces the threat of the patents of its most popular drugs expiring in 2002. The only way to counter the loss of sales from these drugs going off patent is to develop new drugs in order to refresh the company’s portfolio. LAB Pharmaceuticals, a small pharmaceutical company who specializes in the treatment of neurological disorders, has approached Merck with the opportunity to license Davanrik, a new drug with the potential to treat both depression and obesity. The drug is currently in pre-clinical development and would still need to pass a seven year and three phase testing process approved by the FDA. Under the licensing agreement, Merck would compensate LAB with an initial fee, milestone payments as the drug progresses through each phase, and royalty on sales. Merck must make a decision on whether or not to license the drug. If Merck does decide to license the drug, it must also decide how much the drug is worth.…

    • 496 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    The Pharmaceutical industry has several high entry barriers as shown in figure 1. Economies of scale, product differentiation, government policy and capital requirements and financial services are few barriers for new entrant. Level of threat from rivalry is also high in this industry. Industry has presence of large number of small firms of a similar size. They are in direct competition with one another,…

    • 1056 Words
    • 5 Pages
    Good Essays
  • Satisfactory Essays

    Cost of Capital

    • 282 Words
    • 1 Page

    Pfizer is the worlds’ largest research based pharmaceutical company. This company faces many challenges are many challenges just as other major companies do. This company has an estimated $65 billion in world -wide revenue with market cap of $140 billion. The assumption is that the company has a solid financial portfolio, trading 8 billion shares daily, and retaining $7 billion in capital. The company does not fund project by project, it prioritizes the present products to determine which to fund first using a productivity index metric to measure the cost to manufacture the anticipated return on investment. As stated by Emmitt, each product bears unique risks. The patent process protects the company and allows the company to sell the product exclusively on the market. Team B will reflect on some of the corporate finance challenges faced by Pfizer.…

    • 282 Words
    • 1 Page
    Satisfactory Essays
  • Best Essays

    The pharmaceutical company is made up of a number of different functions and departments. Each of these functions is given a responsibility in one area of the company’s activity. These departments are closely related and the success of the company is based on the ability of these functions to work together. The pharmaceutical companies rely on research and development to find new and innovation new drugs. In order for a drug to enter the market it must undergo a series of tests and clinical trials. There are phases the drug must go through and complete in order to meet the requirements of the FDA. The development of a drug is an ongoing journey, and it can take up to 12 years to develop a drug (Pharmaceutical Patents 2006). The pharmaceutical company uses…

    • 4398 Words
    • 18 Pages
    Best Essays
  • Good Essays

    Pfizer Inc. is a large pharmaceutical company that engages in the discovery of new technologies, the manufacture of prescription and "over the counter" (OTC) medicines, as well as the marketing of such products. It operates in three distinct segments that include Human Health, Consumer Healthcare, and Animal Health. For fiscal year 2004, the company generated approximately $53 billion in revenue that contributed to over $11 billion in net income. (Pfizer, 2004)…

    • 1018 Words
    • 5 Pages
    Good Essays
  • Better Essays

    Pharmanet-i3, a subsidiary of inVentive Health, is a world leading clinical research organization committed to the advancement of health around the world. The mission of Pharmanet-i3 is to be a strategic partner to companies that develop therapeutic drugs, and aim to bring drugs to the public that treat disease and improve the quality of life. The company will operate within the industry’s highest quality standards with uncompromising integrity, ethics, and respect for employees, study participants, the environment, and the communities in which the employees live and work. Shareholders can expect superior returns through the implementation of a successful growth strategy (Pharmanet-I3, n.d.).…

    • 1342 Words
    • 6 Pages
    Better Essays
  • Powerful Essays

    Horizontal Analysis Paper

    • 1394 Words
    • 6 Pages

    Pfizer is Pfizer is the world’s leading pharmaceutical company with more than 122,000 employees worldwide and operations in over 150 countries. . Throughout the years, Pfizer has continued to discover, develop and bring to market innovative medicines that treat diseases and improve the quality of patients’ lives. In 2001, they adopted a new mission to…

    • 1394 Words
    • 6 Pages
    Powerful Essays
  • Better Essays

    Fda Research Paper

    • 2368 Words
    • 10 Pages

    Sauer, C., & Sauer, R. M. (2007, October). Is It Possible to Have Cheaper Drugs and Preserve the Incentive to Innovate? The Benefits of Privatizing the Drug Approval Process. Journal of Technology Transfer, 32(5), 509-524. doi:http://dx.doi.org/10.1007/s10961-007-9036-0…

    • 2368 Words
    • 10 Pages
    Better Essays
  • Better Essays

    State Capitalism Model

    • 1295 Words
    • 6 Pages

    "The Ethics of Drug Patents." COMM 104 - Course Package Readings. N.p., n.d. Web. 31 Jan. 2014.…

    • 1295 Words
    • 6 Pages
    Better Essays
  • Good Essays

    Merck Case

    • 587 Words
    • 4 Pages

    Merck had a 14% increase in sales between 1997 and 1998 and 22% increase in sales from 1998 – 1999, and a 13% annual increase in earnings over the same period. Merck’s business strategy consists of two parts: (1) developing and marketing new drugs through internal research, and (2) developing partnerships with smaller biotechnology companies. Since 1995, Merck had launched 15 new products that earned $5.9 billion on sales of $32.7 billion. Furthermore, Merck may agree to license new drugs from other firms and with its larger capital and greater assets, can assume the risk of submitting the drug through various regulatory approval phases. If the drug becomes profitable, Merck can earn significant cash flows while paying a royalty to the licensor. However, most important is the option that Merck has in deciding when to abandon or continue on this project (deferability or optionality). If Merck reaches a point when its expected NPV is negative, it can simply abandon the project. As a licensee, Merck can allow smaller biotechnology firms to focus on research and development. These smaller firms often have smaller budgets and are not financially or personnel equipped to handle the costly and long FDA approval process, and the subsequent marketing, distribution, and sales of new drugs. This task is better suited for a larger company, such as Merck, which has more resources and money.…

    • 587 Words
    • 4 Pages
    Good Essays